Image de couverture de livre

The Backfill i3+3 Design for Dose-Finding Trials in Oncology

Fuente: arXiv

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Liu, Jiaxin, Yuan, Shijie, Bekele, B. Nebiyou, Ji, Yuan
Format:	Preprint
Publié:	2023
Sujets:	Applications
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

The Modified Combo i3+3 Design for Novel-Novel Combination Dose-Finding Trials in Oncology
par: Liu, Jiaxin, et autres
Publié: (2024)

Pharmacometrics-Enabled DOse OPtimization (PEDOOP) for Seamless Phase I-II Trials in Oncology
par: Yuan, Shijie, et autres
Publié: (2023)

Precision Dose-Finding Design for Phase I Oncology Trials by Integrating Pharmacology Data
par: Lee, Kyong Ju, et autres
Publié: (2025)

BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials
par: Chen, Yuxuan, et autres
Publié: (2026)

SIMBA -- A Bayesian Decision Framework for the Identification of Optimal Biomarker Subgroups for Cancer Basket Clinical Trials
par: Yuan, Shijie, et autres
Publié: (2025)

MUCE: Bayesian Hierarchical Modeling for the Design and Analysis of Phase 1b Multiple Expansion Cohort Trials
par: Lyu, Jiaying, et autres
Publié: (2020)

Defining Utility as a Measure of Preference Under Uncertainty in Phase I-II Oncology Dose Finding Trials
par: Hall, Andrew, et autres
Publié: (2025)

A Seamless Phase II/III Design with Dose Optimization for Oncology Drug Development
par: Li, Yuhan, et autres
Publié: (2024)

Learning from Literature: Integrating LLMs and Bayesian Hierarchical Modeling for Oncology Trial Design
par: Gong, Guannan, et autres
Publié: (2026)

Straightforward Phase I Dose-Finding Design for Healthy Volunteers Accounting for Surrogate Activity Biomarkers
par: Boulet, Sandrine, et autres
Publié: (2024)

Regulatory Expectations for Bayesian Methods in Drug and Biologic Clinical Trials: A Practical Perspective on FDA's 2026 Draft Guidance
par: Ji, Yuan, et autres
Publié: (2026)

Adaptive Phase 2/3 Design with Dose Optimization
par: Chen, Cong, et autres
Publié: (2024)

Monitoring Adverse Events Through Bayesian Nonparametric Clustering Across Studies
par: Yuan, Shijie, et autres
Publié: (2025)

Adjustment for Inconsistency in Adaptive Phase 2/3 Designs with Dose Optimization
par: Chen, Cong, et autres
Publié: (2025)

Considerations for Single-Arm Trials to Support Accelerated Approval of Oncology Drugs
par: Lu, Feinan, et autres
Publié: (2024)

Joint TITE-CRM for Dual Agent Dose Finding Studies
par: Barnett, Helen, et autres
Publié: (2025)

Robust Power and Sample Size Calculations in Quasi-likelihood Models: Methods and Practice
par: Yuan, Shijie, et autres
Publié: (2026)

Pharmacokinetic Measurements in Dose Finding Model Guided by Escalation with Overdose Control
par: Maity, Arnab Kumar, et autres
Publié: (2024)

Semiparametric Piecewise Accelerated Failure Time Model for the Analysis of Immune-Oncology Clinical Trials
par: Sunami, Hisato, et autres
Publié: (2024)

CUI-MET: Clinical Utility Index Dose Optimization Approach for Multiple-Dose, Multiple-Outcome Randomized Trial Designs
par: Zhang, Fanni, et autres
Publié: (2025)

On the Calibration of Bayesian Success Criteria and Operating Characteristics for Clinical Trials
par: Yang, Peng, et autres
Publié: (2026)

Evaluation of Minimal Residual Disease as a Surrogate for Progression-Free Survival in Hematology Oncology Trials: A Meta-Analytic Review
par: She, Jane, et autres
Publié: (2026)

Modeling Time-Varying Effects of Mobile Health Interventions Using Longitudinal Functional Data from HeartSteps Micro-Randomized Trial
par: Yu, Jiaxin, et autres
Publié: (2024)

Generalized Design of Basket Trials with P-value Combination Test
par: Zhou, Heng, et autres
Publié: (2024)

Statistical Design and Rationale of the Biomarkers for Evaluating Spine Treatments (BEST) Trial
par: Sperger, John, et autres
Publié: (2025)

Improving Maximum Tolerated Dose Selection in Model-Assisted Designs for Phase I Trials through Bayesian Dose-Response Model
par: Wakayama, Rentaro, et autres
Publié: (2025)

A Bayesian Basket Trial Design Using Local Power Prior
par: Zhou, Haiming, et autres
Publié: (2023)

Age-Dependent Heterogeneity in the Association Between Physical Activity and Mental Distress: A Causal Machine Learning Analysis of 3.2 Million U.S. Adults
par: Shan, Yuan
Publié: (2026)

Bayesian Design and Analysis of Precision Trials with Partial Borrowing
par: Golchi, Shirin, et autres
Publié: (2026)

Two-stage Adaptive Design Cluster Randomised Trials
par: Watson, Samuel I., et autres
Publié: (2026)

Personalized Oncology: Feasibility of Evaluating Treatment Effects for Individual Patients
par: Jang, Lydia, et autres
Publié: (2025)

Adaptive Weighting for Time-to-Event Continual Reassessment Method: Improving Safety in Phase I Dose-Finding Through Data-Driven Delay Distribution Estimation
par: Amevor, Robert, et autres
Publié: (2026)

Hybrid Non-informative and Informative Prior Model-assisted Designs for Mid-trial Dose Insertion
par: Yamada, Kana, et autres
Publié: (2026)

Remote, bivariate expert elicitation to determine the prior probability distribution for sample size calculation in a Bayesian non-inferiority multicenter randomized controlled trial (Croup Dosing Trial)
par: Jiang, Arlene, et autres
Publié: (2026)

On Assessing Overall Survival (OS) in Oncology Studies
par: Hsu, Jason C.
Publié: (2025)

Second-order Asymptotic Analysis of Tail Probabilities of Randomly Weighted Sums: With Applications to a Bidimensional Discrete-time Risk Model
par: Geng, Bingzhen, et autres
Publié: (2025)

Decentralized Clinical Trials in the Era of Real-World Evidence: A Statistical Perspective
par: Chen, Jie, et autres
Publié: (2024)

Dose optimization design accounting for unknown patient heterogeneity in cancer clinical trials
par: Silva, Rebecca B., et autres
Publié: (2025)

Sample size and power determination for assessing overall SNP effects in joint modeling of longitudinal and time-to-event data
par: Bian, Yuan, et autres
Publié: (2026)

Same Prompt, Different Outcomes: Evaluating the Reproducibility of Data Analysis by LLMs
par: Cui, Jiaxin, et autres
Publié: (2026)